IP Library Granted Patent US 10,058,580
Granted Patent B2
US 10,058,580 · App. 14/581,610 · Granted Aug 28, 2018

Herbal composition PHY906 and its use in chemotherapy

Inventors: Shwu-Huey Liu (Madison, CT); Zaoli Jiang (Woodbridge, CT); Yung-Chi Cheng (Woodbridge, CT)
Assignee: YALE UNIVERSITY
A61K36/725A61K31/4412A61K31/7068A61K36/484A61K36/539A61K36/65
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,058,580
App. No.
14/581,610
Granted
Aug 28, 2018
Kind
B2
Abstract

This invention provides herbal compositions useful for increasing the therapeutic index of chemotherapeutic compounds. This invention also provides methods useful for improving the quality of life of an individual undergoing chemotherapy. Furthermore, this invention improves the treatment of disease by increasing the therapeutic index of chemotherapy drugs by administering the herbal composition PHY906 to a mammal undergoing such chemotherapy.

Claims (23)

1. A method of increasing the therapeutic index of sorafenib by administering to a mammal to which sorafenib has been administered a therapeutically effective amount of an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia.

2. A method of treating cancer in a mammal in need thereof comprising administering to the mammal a therapeutically effective amount of:

i) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia ; and

iii) a chemotherapeutic formulation comprising sorafenib.

3. The method of claim 2 , wherein the cancer is a gastrointestinal cancer.

4. A method of relieving side effects of sorafenib in a mammal comprising administering to the mammal a therapeutically effective amount of:

i) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia ; and

iii) a chemotherapeutic formulation comprising sorafenib.

5. A method of enhancing therapeutic effectiveness of sorafenib in a mammal comprising administering to the mammal a therapeutically effective amount of:

i) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia ; and

iii) a chemotherapeutic formulation comprising sorafenib.

6. A method of using sorafenib, comprising administering to a mammal in need thereof a therapeutically effective amount of:

i) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia ; and

iii) a chemotherapeutic formulation comprising sorafenib.

7. A method of improving the quality of life of a mammal being treated with sorafenib comprising administering a therapeutically effective amount of a chemotherapeutic formulation comprising sorafenib and an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia.

8. A method of inhibiting the growth of tumors comprising administering to a mammal in need thereof:

i) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus , and Paeonia ; and

iii) a chemotherapeutic formulation comprising sorafenib.

9. The method of claim 8 , wherein the tumors are present in a mammal or in vitro cells.

10. The method of any one of claims, 1 , 2 , 4 , 5 , 6 , 7 , and 9 wherein the mammal is human.

11. The method of any one of the claims 1 , 2 , 4 , 5 , 6 , 7 , and 8 , wherein the herbal preparation comprises Scutellaria baicalensis, Glycyrrhiza uralensis, Ziziphus jujuba , and Paeonia lactiflora.

12. The method of any one of the claims 2 , 4 , 5 , 6 , 7 , and 8 , wherein the herbal preparation is administered via oral route and sorafenib is administered via oral route.

13. The method of claim 12 , wherein the herbal preparation is administered before sorafenib is administered.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2021
From: MACQUARIE US TRADING LLC
To: KADMON CORPORATION, LLC
Reel/Frame 057973/0751 →
TERMINATION OF PATENT AND TRADEMARK SECURITY AGREEMENT Recorded Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON CORPORATION, LLC
Reel/Frame 051106/0677 →
SECURITY INTEREST Recorded Sep 8, 2015
From: KADMON CORPORATION, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036573/0001 →
SECURITY INTEREST Recorded Aug 31, 2015
From: KADMON CORPORATION, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036515/0084 →
Continuity (4)
Continuation 13648597 · Oct 10, 2012
Continuation 12527302
Provisional Application 60901310 · Feb 15, 2007
Related Publication 20150110906A1 · Apr 23, 2015